Abeona Therapeutics (ABEO) Asset Writedowns and Impairment (2022)
Abeona Therapeutics (ABEO) recorded quarterly Asset Writedowns and Impairment of $711000.0 in Q4 2022, up 197.49% quarter-over-quarter from $239000.0 in Q3 2022.
Abeona Therapeutics (ABEO) Asset Writedowns and Impairment (2022) Analysis & Trends
Abeona Therapeutics' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $711000.0 for Q4 2022.
- In Q4 2022, Asset Writedowns and Impairment changed N/A year-over-year to $711000.0; the TTM figure through Dec 2023 stood at $950000.0 (down 62.17% YoY), while the FY2023 annual figure was -$1.1 million, down 142.41% from the prior year.
- Asset Writedowns and Impairment was $711000.0 for Q4 2022 at Abeona Therapeutics, up from $239000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $3.3 million in Q1 2022 to a low of -$1.7 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 711,000.00 |
| Dec 31, 2022 | 711,000.00 |
| Sep 30, 2022 | 239,000.00 |
| Sep 30, 2022 | 239,000.00 |
| Jun 30, 2022 | -1.69 Mn |
| Jun 30, 2022 | -1.69 Mn |
| Mar 31, 2022 | 3.25 Mn |
| Mar 31, 2022 | 3.25 Mn |